Uterine plasminogen activator activity: Modulation by steroid hormones

Mark A. Kneifel, Steven P. Leytus, Estelle Fletcher, Thomas Weber, Walter F. Mangel, Benita S Katzenellenbogen

Research output: Contribution to journalArticle

Abstract

We have used a sensitive and quantitative assay to investigate the hormonal regulation of plasminogen activator (PA) activity in the rat uterus. PA activity is increased 5-fold (per U protein or DNA) by low physiological (0.1 μg) doses of estradiol, with increases in activity first observed at approximately 12 h. The stimulation of PA activity shows strict specificity among the steroid hormones, being stimulated by estrogens only or by high doses of dihydrotestosterone, which are known to affect the estrogen receptor system, and this stimulation is suppressed markedly by triphenylethylene antiestrogens. Comparative dose-response studies with a variety of estrogens of different uterotropic potencies indicate a good correlation between the potencies of different estrogens in stimulating PA activity and uterine growth (diethylstilbestrol = 17β-estradiol < estrone = 17α-estradiol < estriol), with the exception of the zearalanol estrogen P-1496, which was consistently a potent stimulator of PA activity while being a very weak uterotropic agent. These studies suggest that increases in uterine PA levels may serve as a good marker of estrogen action in the uterus. Although the role of PA in uterine function remains unknown at present, its relatively large increase (up to 25-fold increase in content per uterus) may play a role in tissue remodeling during uterine growth.

Original languageEnglish (US)
Pages (from-to)493-499
Number of pages7
JournalEndocrinology
Volume111
Issue number2
DOIs
StatePublished - Aug 1982

Fingerprint

Plasminogen Activators
Steroids
Hormones
Estrogens
Zeranol
Uterus
Estradiol
Estriol
Diethylstilbestrol
Estrogen Receptor Modulators
Estrone
Dihydrotestosterone
Growth
Estrogen Receptors
DNA
Proteins

ASJC Scopus subject areas

  • Endocrinology

Cite this

Kneifel, M. A., Leytus, S. P., Fletcher, E., Weber, T., Mangel, W. F., & Katzenellenbogen, B. S. (1982). Uterine plasminogen activator activity: Modulation by steroid hormones. Endocrinology, 111(2), 493-499. https://doi.org/10.1210/endo-111-2-493

Uterine plasminogen activator activity : Modulation by steroid hormones. / Kneifel, Mark A.; Leytus, Steven P.; Fletcher, Estelle; Weber, Thomas; Mangel, Walter F.; Katzenellenbogen, Benita S.

In: Endocrinology, Vol. 111, No. 2, 08.1982, p. 493-499.

Research output: Contribution to journalArticle

Kneifel, MA, Leytus, SP, Fletcher, E, Weber, T, Mangel, WF & Katzenellenbogen, BS 1982, 'Uterine plasminogen activator activity: Modulation by steroid hormones', Endocrinology, vol. 111, no. 2, pp. 493-499. https://doi.org/10.1210/endo-111-2-493
Kneifel, Mark A. ; Leytus, Steven P. ; Fletcher, Estelle ; Weber, Thomas ; Mangel, Walter F. ; Katzenellenbogen, Benita S. / Uterine plasminogen activator activity : Modulation by steroid hormones. In: Endocrinology. 1982 ; Vol. 111, No. 2. pp. 493-499.
@article{5e0d1a4438b848a8856c671b381af60b,
title = "Uterine plasminogen activator activity: Modulation by steroid hormones",
abstract = "We have used a sensitive and quantitative assay to investigate the hormonal regulation of plasminogen activator (PA) activity in the rat uterus. PA activity is increased 5-fold (per U protein or DNA) by low physiological (0.1 μg) doses of estradiol, with increases in activity first observed at approximately 12 h. The stimulation of PA activity shows strict specificity among the steroid hormones, being stimulated by estrogens only or by high doses of dihydrotestosterone, which are known to affect the estrogen receptor system, and this stimulation is suppressed markedly by triphenylethylene antiestrogens. Comparative dose-response studies with a variety of estrogens of different uterotropic potencies indicate a good correlation between the potencies of different estrogens in stimulating PA activity and uterine growth (diethylstilbestrol = 17β-estradiol < estrone = 17α-estradiol < estriol), with the exception of the zearalanol estrogen P-1496, which was consistently a potent stimulator of PA activity while being a very weak uterotropic agent. These studies suggest that increases in uterine PA levels may serve as a good marker of estrogen action in the uterus. Although the role of PA in uterine function remains unknown at present, its relatively large increase (up to 25-fold increase in content per uterus) may play a role in tissue remodeling during uterine growth.",
author = "Kneifel, {Mark A.} and Leytus, {Steven P.} and Estelle Fletcher and Thomas Weber and Mangel, {Walter F.} and Katzenellenbogen, {Benita S}",
year = "1982",
month = "8",
doi = "10.1210/endo-111-2-493",
language = "English (US)",
volume = "111",
pages = "493--499",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Uterine plasminogen activator activity

T2 - Modulation by steroid hormones

AU - Kneifel, Mark A.

AU - Leytus, Steven P.

AU - Fletcher, Estelle

AU - Weber, Thomas

AU - Mangel, Walter F.

AU - Katzenellenbogen, Benita S

PY - 1982/8

Y1 - 1982/8

N2 - We have used a sensitive and quantitative assay to investigate the hormonal regulation of plasminogen activator (PA) activity in the rat uterus. PA activity is increased 5-fold (per U protein or DNA) by low physiological (0.1 μg) doses of estradiol, with increases in activity first observed at approximately 12 h. The stimulation of PA activity shows strict specificity among the steroid hormones, being stimulated by estrogens only or by high doses of dihydrotestosterone, which are known to affect the estrogen receptor system, and this stimulation is suppressed markedly by triphenylethylene antiestrogens. Comparative dose-response studies with a variety of estrogens of different uterotropic potencies indicate a good correlation between the potencies of different estrogens in stimulating PA activity and uterine growth (diethylstilbestrol = 17β-estradiol < estrone = 17α-estradiol < estriol), with the exception of the zearalanol estrogen P-1496, which was consistently a potent stimulator of PA activity while being a very weak uterotropic agent. These studies suggest that increases in uterine PA levels may serve as a good marker of estrogen action in the uterus. Although the role of PA in uterine function remains unknown at present, its relatively large increase (up to 25-fold increase in content per uterus) may play a role in tissue remodeling during uterine growth.

AB - We have used a sensitive and quantitative assay to investigate the hormonal regulation of plasminogen activator (PA) activity in the rat uterus. PA activity is increased 5-fold (per U protein or DNA) by low physiological (0.1 μg) doses of estradiol, with increases in activity first observed at approximately 12 h. The stimulation of PA activity shows strict specificity among the steroid hormones, being stimulated by estrogens only or by high doses of dihydrotestosterone, which are known to affect the estrogen receptor system, and this stimulation is suppressed markedly by triphenylethylene antiestrogens. Comparative dose-response studies with a variety of estrogens of different uterotropic potencies indicate a good correlation between the potencies of different estrogens in stimulating PA activity and uterine growth (diethylstilbestrol = 17β-estradiol < estrone = 17α-estradiol < estriol), with the exception of the zearalanol estrogen P-1496, which was consistently a potent stimulator of PA activity while being a very weak uterotropic agent. These studies suggest that increases in uterine PA levels may serve as a good marker of estrogen action in the uterus. Although the role of PA in uterine function remains unknown at present, its relatively large increase (up to 25-fold increase in content per uterus) may play a role in tissue remodeling during uterine growth.

UR - http://www.scopus.com/inward/record.url?scp=0020170492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020170492&partnerID=8YFLogxK

U2 - 10.1210/endo-111-2-493

DO - 10.1210/endo-111-2-493

M3 - Article

C2 - 7201382

AN - SCOPUS:0020170492

VL - 111

SP - 493

EP - 499

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 2

ER -